Literature DB >> 10050784

Evaluation of cryoglobulins.

U Kallemuchikkal1, P D Gorevic.   

Abstract

Cryoglobulins are immunoglobulins that precipitate as serum is cooled below core body temperatures. A cryoglobulin screen is the observation of a serum specimen collected and separated while warm for cryoprecipitation over a period of up to 7 days. Values of the screening may be reported as a cryocrit, which is the volume percent of the precipitate compared with the total volume of serum. Further proof that the precipitate is indeed a cryoglobulin can be obtained by demonstrating resolubilization with warming and immunochemical analysis by immunofixation. Detailed characterization of cryoglobulins may also require rigorous washing of the precipitate, quantitation of total protein and immunoglobulins, and evaluation of serum for monoclonal gammopathy, rheumatoid factor activity, evidence of complement activation, and presence of hepatitis C virus seroreactivity or hepatitis C virus RNA. The single most important variable confounding standardization of cryoglobulin testing is the frequently improper separation of warm serum from other blood elements prior to screening and characterization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10050784     DOI: 10.5858/1999-123-0119-EOC

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  18 in total

1.  Immunochemical composition of cryoglobulins generated in stroke.

Authors:  Levon Manukyan; Anna Boyajyan; Arsen Arakelyan; Violetta Ayvazyan; Elina Arakelova; Robert Sim; George Grigoryan
Journal:  J Clin Immunol       Date:  2008-11-04       Impact factor: 8.317

Review 2.  HCV-negative mixed cryoglobulinemia and kidney involvement: in-depth review on physiopathological and histological bases.

Authors:  Leonardo Spatola; Elena Generali; Claudio Angelini; Salvatore Badalamenti; Carlo Selmi
Journal:  Clin Exp Med       Date:  2018-06-28       Impact factor: 3.984

3.  Hepatitis C virus positive patient diagnosed after detection of atypical cryoglobulin.

Authors:  Belkiz Ongen; Fehime Benli Aksungar; Bahattin Cicek; Isin Akyar; Abdurrahman Coskun; Mustafa Serteser; Ibrahim Unsal
Journal:  World J Clin Cases       Date:  2016-03-16       Impact factor: 1.337

4.  Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice.

Authors:  S Taneda; S Segerer; K L Hudkins; Y Cui; M Wen; M Segerer; M H Wener; C G Khairallah; A G Farr; C E Alpers
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

5.  Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.

Authors:  Neal J Schamberg; Gerond V Lake-Bakaar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

Review 6.  Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma.

Authors:  Aroonima Misra; Jyoti Mishra; Jagan Chandramohan; Atul Sharma; Vinod Raina; Rajive Kumar; Sushant Soni; Anita Chopra
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-13       Impact factor: 0.900

7.  B cell non-Hodgkin's lymphoma in chronic hepatitis C virus patients: An interesting relationship.

Authors:  Hassan S Hamdy; Nadia A Abdelkader; Amal Mansour; Enas H Allam; Hisham M El-Wakiel; Dina Elshenawy
Journal:  Indian J Gastroenterol       Date:  2015-04-29

8.  Membranoproliferative glomerulonephritis with essential cryoglobulinemia.

Authors:  S Satish; R Rajesh; K George; E M Elango; V N Unni
Journal:  Indian J Nephrol       Date:  2008-04

9.  Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia.

Authors:  Edgar D Charles; Rashidah M Green; Svetlana Marukian; Andrew H Talal; Gerond V Lake-Bakaar; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

10.  Severe, refractory, non-malignant type I cryoglobulinemia treated with alemtuzumab.

Authors:  David Chu; Michelle Stevens; Douglas Edward Gladstone
Journal:  Rheumatol Int       Date:  2007-04-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.